References
1. Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: updates in
pathogenesis, definitions, and guidelines. Clinical Journal of the
American Society of Nephrology. 2016;11(6):1102-13.
2. Harmon QE, Huang L, Umbach DM, Klungsøyr K, Engel SM, Magnus P, et
al. Risk of fetal death with preeclampsia. Obstetrics and gynecology.
2015;125(3):628.
3. Alkema L, Chou D, Hogan D, Zhang S, Moller A-B, Gemmill A, et al.
Global, regional, and national levels and trends in maternal mortality
between 1990 and 2015, with scenario-based projections to 2030: a
systematic analysis by the UN Maternal Mortality Estimation Inter-Agency
Group. The Lancet. 2016;387(10017):462-74.
4. Lee QY, Odoi AT, OPARE‐ADDO H, Dassah ET. Maternal mortality in
Ghana: a hospital‐based review. Acta obstetricia et gynecologica
Scandinavica. 2012;91(1):87-92.
5. Dassah ET, Kusi-Mensah E, Morhe ES, Odoi AT. Maternal and perinatal
outcomes among women with hypertensive disorders in pregnancy in Kumasi,
Ghana. PloS one. 2019;14(10):e0223478.
6. Salam RA, Das JK, Ali A, Bhaumik S, Lassi ZS. Diagnosis and
management of preeclampsia in community settings in low and
middle-income countries. J Family Med Prim Care. 2015;4(4):501-6.
7. Rawlins B, Plotkin M, Rakotovao JP, Getachew A, Vaz M, Ricca J, et
al. Screening and management of pre-eclampsia and eclampsia in antenatal
and labor and delivery services: findings from cross-sectional
observation studies in six sub-Saharan African countries. BMC Pregnancy
and Childbirth. 2018;18(1):346.
8. Jim B, Karumanchi SA, editors. Preeclampsia: pathogenesis,
prevention, and long-term complications. Seminars in nephrology; 2017:
Elsevier.
9. Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S.
Angiogenesis in the placenta: the role of reactive oxygen species
signaling. BioMed research international. 2015;2015.
10. Anto EO, Roberts P, Turpin CA, Wang W. Oxidative stress as a key
signaling pathway in placental angiogenesis changes in preeclampsia:
updates in pathogenesis, novel biomarkers and therapeutics. Current
Pharmacogenomics and Personalized Medicine (Formerly Current
Pharmacogenomics). 2018;16(3):167-81.
11. Yoshida A, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Wakatsuki
A. Placental oxidative stress and maternal endothelial function in
pregnant women with normotensive fetal growth restriction. The Journal
of Maternal-Fetal & Neonatal Medicine. 2018;31(8):1051-7.
12. Wu F, Tian F-J, Lin Y, Xu W-M. Oxidative Stress: Placenta Function
and Dysfunction. American Journal of Reproductive Immunology.
2016;76(4):258-71.
13. Lou W-z, Jiang F, Hu J, Chen X-x, Song Y-n, Zhou X-y, et al.
Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A
Useful Marker for Differential Diagnosis and Prognosis Evaluation in
Chinese Women. Disease Markers. 2019;2019.
14. Honigberg M, Cantonwine D, Thomas A, Lim K, Parry S, McElrath T.
Analysis of changes in maternal circulating angiogenic factors
throughout pregnancy for the prediction of preeclampsia. Journal of
Perinatology. 2016;36(3):172-7.
15. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch
E, et al. A prospective cohort study of the value of maternal plasma
concentrations of angiogenic and anti-angiogenic factors in early
pregnancy and midtrimester in the identification of patients destined to
develop preeclampsia. The Journal of Maternal-Fetal & Neonatal
Medicine. 2009;22(11):1021-38.
16. Anto EO, Roberts P, Coall DA, Adua E, Turpin CA, Tawiah A, et al.
Suboptimal health pregnant women are associated with increased oxidative
stress and unbalanced pro-and antiangiogenic growth mediators: a
cross-sectional study in a Ghanaian population. Free Radical Research.
2020;54(1):27-42.
17. Anto EO, Roberts P, Coall D, Turpin CA, Adua E, Wang Y, et al.
Integration of suboptimal health status evaluation as a criterion for
prediction of preeclampsia is strongly recommended for healthcare
management in pregnancy: a prospective cohort study in a Ghanaian
population. EPMA Journal. 2019;10(3):211-26.
18. Agrawal S, Cerdeira AS, Redman C, Vatish M. Meta-analysis and
systematic review to assess the role of soluble FMS-like tyrosine
kinase-1 and placenta growth factor ratio in prediction of preeclampsia:
the SaPPPhirE study. Hypertension. 2018;71(2):306-16.
19. Caillon H, Tardif C, Dumontet E, Winer N, Masson D. Evaluation of
sFlt-1/PlGF ratio for predicting and improving clinical management of
pre-eclampsia: experience in a specialized perinatal care center. Annals
of laboratory medicine. 2018;38(2):95-101.
20. Turpin CA, Sakyi SA, Owiredu WKBA, Ephraim RKD, Anto EO. Association
between adverse pregnancy outcome and imbalance in angiogenic regulators
and oxidative stress biomarkers in gestational hypertension and
preeclampsia. BMC Pregnancy and Childbirth. 2015;15(1):189.
21. Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J.
[Predictive value of the sFlt1/PlGF ratio for the diagnosis of
preeclampsia in high-risk patients]. Zeitschrift fur Geburtshilfe und
Neonatologie. 2014;218(1):34-41.
22. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler
H, et al. The sFlt-1/PlGF ratio in different types of hypertensive
pregnancy disorders and its prognostic potential in preeclamptic
patients. American journal of obstetrics and gynecology.
2012;206(1):58.e1-8.
23. Pratt A, Da Silva Costa F, Borg AJ, Kalionis B, Keogh R, Murthi P.
Placenta-derived angiogenic proteins and their contribution to the
pathogenesis of preeclampsia. Angiogenesis. 2015;18(2):115-23.
24. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia.
Nature clinical practice Nephrology. 2005;1(2):98-114.
25. O’Brien M, Baczyk D, Kingdom JC. Endothelial dysfunction in severe
preeclampsia is mediated by soluble factors, rather than extracellular
vesicles. Scientific reports. 2017;7(1):1-12.
26. Chuchracki M, Pisarska M, Krzyścin M. The role of sFLT-1 and PlGF
factors as well as the sFLT-1/PlGF ratio as a predictor of gestational
hypertension and preeclampsia. Arch Perinat Med. 2017;23(2):97-104.
27. Park HJ, Kim SH, Jung YW, Shim SS, Kim JY, Cho YK, et al. Screening
models using multiple markers for early detection of late-onset
preeclampsia in low-risk pregnancy. BMC pregnancy and childbirth.
2014;14(1):35.
28. Weel IC, Baergen RN, Romão-Veiga M, Borges VT, Ribeiro VR, Witkin
SS, et al. Association between Placental Lesions, Cytokines and
Angiogenic Factors in Pregnant Women with Preeclampsia. PLOS ONE.
2016;11(6):e0157584.
Table 1.
Demographics, obstetrics, single biomarkers of OS and AGMs and their
combination among SHS and OHS pregnant women who developed EO-PE and
LO-PE compared to NTN-P